Cytox (AgeTech UK) NeuroTech
Cytox Group Limited provides non-invasive, risk assessment and patient stratification tools for Alzheimer's disease and dementia. Cytox’s mission is to transform how new treatments are developed, people are screened, and how patients are managed within the Alzheimer’s disease care pathway.
Connections from
Funding Status:
N/A
Industry:
UK AgeTech 2020
Number Of Exists:
N/A
Technology:
AgeTech Companies
Founded Date:
N/A
Investor Type:
N/A
Headquarters:
United Kingdom
Employee Number:
N/A
Investment Stage:
N/A